Biochemical properties of anti-inflammatory drugs. 8. Inhibition of histamine formation catalyzed by substrate specific mammalian histidine decarboxylases. Drug antagonism of aldehyde binding to protein amino groups.
D000447:Aldehydes / Q000378:metabolism*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002262:Carboxy-Lyases; D003124:Colorimetry; D005321:Extraembryonic Membranes / Q000032:analysis; D005439:Flufenamic Acid / Q000494:pharmacology; D005753:Gastric Mucosa / Q000032:analysis; D006035:Glycyrrhiza; D006046:Gold / Q000494:pharmacology; D006632:Histamine / Q000032:analysis* / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology; D010085:Oxidative Phosphorylation; D010636:Phenols / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010946:Plants, Medicinal; D011485:Protein Binding; D011732:Pyridoxal Phosphate / Q000378:metabolism*; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D012710:Serum Albumin, Bovine; D013729:Terpenes / Q000494:pharmacology; D013885:Thiosulfates / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000447:Aldehydes; D000893:Anti-Inflammatory Agents; D010636:Phenols; D010648:Phenylacetates; D012459:Salicylates; D013729:Terpenes; D013885:Thiosulfates; D062367:ortho-Aminobenzoates; D012710:Serum Albumin, Bovine; D011732:Pyridoxal Phosphate; D005439:Flufenamic Acid; D006046:Gold; D006632:Histamine; D002262:Carboxy-Lyases; D010653:Phenylbutazone; D007213:Indomethacin